Focal therapies for cancer have been around for more than two decades and have been accepted treatment options for breast and renal cancers. Gaining acceptance for prostate cancer, however, has been a long-winding road.
Is mpMRI the Key to Making Smarter Use of Ablative Technologies?
By
Sonacare Medical Published: April 03, 2018, 01:00 PM
Making Efficient Use of mpMRI Data
By
Sonacare Medical Published: March 27, 2018, 01:00 PM
With the growing acceptance of the value of multi-parametric MRI (mpMRI) the detection, diagnosis and treatment of prostate cancer is undergoing a paradigm shift away from biomarkers and standard 12-core biopsies to imaging-based strategies with targeted biopsies.